Bruno Vogt
Early Complications in Kidney Donors and Course of Health-related Quality of Life 12 mo After Donation: An Analysis of the Swiss Organ Living-Donor Health Registry.
Brügger C, Hunkeler Z, Diebold M, Krättli J, Geiger I, Wehmeier C, Wolff T, Vogt B, Storni F, Golshayan D, Zingg T, de Seigneux S, Haidar F, Binet F, Schnyder A, Hübel K, Müller T, Rössler F, Steiger J, Hirt-Minkowski P. Early Complications in Kidney Donors and Course of Health-related Quality of Life 12 mo After Donation: An Analysis of the Swiss Organ Living-Donor Health Registry. Transplant Direct 2024; 10:e1716.
Oct 10, 2024Early Complications in Kidney Donors and Course of Health-related Quality of Life 12 mo After Donation: An Analysis of the Swiss Organ Living-Donor Health Registry.
Oct 10, 2024Transplant Direct 2024; 10:e1716
Brügger Charlotte, Hunkeler Zoé, Diebold Matthias, Krättli Joana, Geiger Irene, Wehmeier Caroline, Wolff Thomas, Vogt Bruno, Storni Federico, Golshayan Délaviz, Zingg Tobias, de Seigneux Sophie, Haidar Fadi, Binet Françoise-Isabelle, Schnyder Aurelia, Hübel Kerstin, Müller Thomas F, Rössler Fabian, Steiger Jürg, Hirt-Minkowski Patricia
The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria.
Dhayat N, Mattmann C, Seeger H, Ritter A, Ernandez T, Stoermann-Chopard C, Buchkremer F, Segerer S, Roth B, Wuerzner G, Wagner C, Bonny O, Popp A, Vogt B, Bargagli M, Fuster D. The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria. Kidney Int Rep 2024; 9:1072-1082.
Jan 10, 2024The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria.
Jan 10, 2024Kidney Int Rep 2024; 9:1072-1082
Dhayat Nasser A, Mattmann Cédric, Seeger Harald, Ritter Alexander, Ernandez Thomas, Stoermann-Chopard Catherine, Buchkremer Florian, Segerer Stephan, Roth Beat, Wuerzner Gregoire, Wagner Carsten A, Bonny Olivier, Popp Albrecht W, Vogt Bruno, Bargagli Matteo, Fuster Daniel G
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Dhayat N, Bonny O, Roth B, Christe A, Ritter A, Mohebbi N, Faller N, Pellegrini L, Bedino G, Venzin R, Grosse P, Hüsler C, Koneth I, Bucher C, Del Giorno R, Gabutti L, Mayr M, Odermatt U, Buchkremer F, Ernandez T, Stoermann-Chopard C, Teta D, Vogt B, Roumet M, Tamò L, Cereghetti G, Trelle S, Fuster D. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. N Engl J Med 2023; 388:781-791.
Mar 2, 2023Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Mar 2, 2023N Engl J Med 2023; 388:781-791
Dhayat Nasser A, Bonny Olivier, Roth Beat, Christe Andreas, Ritter Alexander, Mohebbi Nilufar, Faller Nicolas, Pellegrini Lisa, Bedino Giulia, Venzin Reto M, Grosse Philipp, Hüsler Carina, Koneth Irene, Bucher Christian, Del Giorno Rosaria, Gabutti Luca, Mayr Michael, Odermatt Urs, Buchkremer Florian, Ernandez Thomas, Stoermann-Chopard Catherine, Teta Daniel, Vogt Bruno, Roumet Marie, Tamò Luca, Cereghetti Grazia M, Trelle Sven, Fuster Daniel G
Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology.
Zanchi A, Jehle A, Lamine F, Vogt B, Czerlau C, Bilz S, Seeger H, de Seigneux S. Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology. Swiss Med Wkly 2023; 153:40004.
Jan 6, 2023Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology.
Jan 6, 2023Swiss Med Wkly 2023; 153:40004
Zanchi Anne, Jehle Andreas W, Lamine Faiza, Vogt Bruno, Czerlau Cecilia, Bilz Stefan, Seeger Harald, de Seigneux Sophie
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
Dhayat N, Faller N, Bonny O, Mohebbi N, Ritter A, Pellegrini L, Bedino G, Schönholzer C, Venzin R, Hüsler C, Koneth I, Del Giorno R, Gabutti L, Amico P, Mayr M, Odermatt U, Buchkremer F, Ernandez T, Stoermann-Chopard C, Teta D, Rintelen F, Roumet M, Irincheeva I, Trelle S, Tamò L, Roth B, Vogt B, Fuster D. Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial. BMC Nephrol 2018; 19:349.
Dec 10, 2018Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
Dec 10, 2018BMC Nephrol 2018; 19:349
Dhayat Nasser A, Faller Nicolas, Bonny Olivier, Mohebbi Nilufar, Ritter Alexander, Pellegrini Lisa, Bedino Giulia, Schönholzer Carlo, Venzin Reto M, Hüsler Carina, Koneth Irene, Del Giorno Rosaria, Gabutti Luca, Amico Patrizia, Mayr Michael, Odermatt Urs, Buchkremer Florian, Ernandez Thomas, Stoermann-Chopard Catherine, Teta Daniel, Rintelen Felix, Roumet Marie, Irincheeva Irina, Trelle Sven, Tamò Luca, Roth Beat, Vogt Bruno, Fuster Daniel G